文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

波兰国家免疫规划引入PCV 10疫苗四年后对社区获得性肺炎住院的影响:随访研究

Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study.
PubMed 文献 · Vaccine · 2024-04-18

该研究基于波兰全国医院发病率数据,分析2009-2016年(PCV 10引入前)与2017-2020年(引入后)社区获得性肺炎(CAP)住院及院内死亡变化。2009-2020年共1,503,105例CAP住院,0.7%由肺炎链球菌引起;CAP住院占比在2009-2016年显著上升,2017年后各年龄组均显著下降(p<0.001)。作者认为PCV接种规划有效降低了CAP住院率,包括<2岁儿童,≥60岁人群死亡风险最高。

要点

  • 2009-2020年CAP住院共1,503,105例,其中0.7%由肺炎链球菌引起。
  • CAP住院占比2009-2016年显著上升,2017年后各年龄组显著下降(p<0.001)。
  • 2009-2020年CAP院内死亡84,367例,0.5%由肺炎链球菌引起,主要为≥60岁患者。

核心结论

  • 实施PCV接种规划有效降低了CAP住院发生率,包括<2岁儿童。
  • 死亡风险最高的人群是≥60岁者。
  • 研究结果可用于评估疫苗效力与效益,并可作为公共卫生政策的重要部分。
  • 应在不同年龄组实施有效的CAP预防策略。

研究设计与样本

  • 研究分析波兰2009-2016年(PCV 10引入前)与2017-2020年(引入后)的CAP住院及院内死亡变化。
  • 数据来自全国综合医院发病率研究(Nationwide General Hospital Morbidity Study)。
  • 分析年龄组为<2、2-3、4-5、6-19、20-59、60+岁。

主要发现

  • 2009-2020年CAP相关住院共1,503,105例,其中0.7%由肺炎链球菌感染引起。
  • 按每10万人口计,<2岁儿童CAP住院最多,其次为2-3岁、4-5岁和60+岁患者。
  • 2009-2016年CAP住院入院百分比显著上升,2017年后各年龄组均显著下降(p<0.001)。
  • 2009-2016年<2、2-3和4-5岁组肺炎链球菌感染住院显著增加(p<0.05)。
  • 2017-2020年<2、20-59和60+岁组住院显著减少(p<0.05)。

临床怎么用

  • 作者认为研究结果可用于评估疫苗效力与效益,并可作为公共卫生政策的重要部分。
  • 作者提出应在不同年龄组实施有效的CAP预防策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccination against pneumococci is currently the most effective method of protection against pneumococcal infections. The aim of the study was to analyse changes in hospitalisations and in-hospital deaths due to pneumonia before (2009-2016) and after (2017-2020) the introduction of PCV 10 vaccinations in the National Immunisation Programme in Poland. METHODS: Data on hospitalisations related to community acquired pneumonia (CAP) in the years 2009-2020 were obtained from the Nationwide General Hospital Morbidity Study. Analyses were made in the age groups: <2, 2-3, 4-5, 6-19, 20-59, 60+ years in 2009-2016 and 2017-2020. RESULTS: Overall, there were 1,503,105 CAP-related hospitalisations in 2009-2020, 0.7% of which were caused by Streptococcus pneumoniae infections. Children <2 years of age were the most frequently hospitalised for CAP per 100,000 population, followed by patients aged 2-3, 4-5 and 60+ years. In the years 2009-2016, the percentage of CAP hospital admissions increased significantly, and after the year 2017, it decreased significantly in each of the age groups (p<0.001). In the years 2009-2016, a significant increase in hospitalisations for Streptococcus pneumoniae infections was observed in the age groups <2, 2-3 and 4-5 years (p<0.05). A significant reduction in hospitalisations was observed in the age groups <2, 20-59 and 60+ in 2017-2020 (p<0.05). In the years 2009-2020, there were 84,367 in-hospital deaths due to CAP, 423 (0.5%) of which due to Streptococcus pneumoniae, with patients mainly aged 60+. CONCLUSIONS: Implementation of the PCV vaccination programme has effectively decreased the incidence of CAP hospitalisations, including children <2 years of age. The group that is most at risk of death are persons aged 60+. The results of our study can be useful in evaluating the vaccine efficacy and benefits, and they can be an essential part of public health policy. Effective prevention strategies for CAP should be implemented in different age groups.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gajewska M, Lewtak K, Goryński P, et al. Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study. Vaccine. 2024. PMID: 38641493. doi:10.1016/j.vaccine.2024.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。